Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P200045/S025

RelayPro Thoracic Stent-Graft Delivery System

Bolton Medical, Inc. · Decision date Oct 28, 2026

MEDTECHLEDGER EXPLANATIONP200045/S025

What did the FDA decide?

FDA recorded a 30-Day Notice decision coded OK30 on 2026-10-28 for supplement P200045/S025 to PMA P200045, submitted by Bolton Medical, Inc. for the RelayPro Thoracic Stent-Graft Delivery System. The supplement type is listed as a 30-Day Notice with the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier, and the recorded statement describes combining two delivery system components into a single component for the RelayPro Thoracic Stent-Graft System.

The record covers a manufacturing process change to the delivery system rather than a new approval of the full stent-graft system, and the source does not describe the affected components, the sterilization or packaging sites involved, or any conditions attached to the decision. The device category is listed as SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT, with Cardiovascular specialty and product code MIH. No supporting documents were included, so the basis for OK30 and any clinical implications remain unknown from this record.

FDA approval order statement

combination of two delivery system components into a single component for the RelayPro Thoracic Stent-Graft System
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 28, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P200045/S025
Regulatory pathway
PMA supplement
Product code
MIH
Decision code
OK30
Decision date
Oct 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.

Product code
MIH
FDA device class
3

For the original device and its historical approval scope, see PMA P200045. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P200045 · Original PMA

    RelayPro Thoracic Stent-Graft System

  2. P200045/S025 received

    Application receipt date recorded by FDA.

  3. P200045/S025 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P200045. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200045

Product / regulatory recordCompanyPathwayDecision dateSource
Bolton Medical, Inc.PMA approvalAug 5, 2021FDA

Explore the linked device profile

Other records with product code MIH

Product / regulatory recordCompanyPathwayDecision dateSource
Cook, Inc.PMA supplementSep 17, 2026FDA
Cook, Inc.PMA approvalMay 23, 2003FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Bolton Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
799 International Pkwy., Sunrise, FL, 33325

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records